Thailand MoPH Medical Device Registration Services
Cisema provides strategic regulatory support for medical device and in-vitro diagnostic (IVD) manufacturers preparing to enter the Thai market. We support early-stage planning, feasibility evaluations, and regulatory roadmap development for future registration with Thailand’s Ministry of Public Health (MoPH).
With deep insight into Thailand’s evolving regulatory landscape and ASEAN harmonization frameworks, Cisema is your trusted partner for navigating the complexities of market entry planning.
What Sets Cisema Apart in Thailand Medical Device Registration
Cisema’s approach goes beyond basic consulting — we offer structured, insight-driven services to build your regulatory readiness in Thailand:
Our team brings deep knowledge of Thailand’s Ministry of Public Health regulations and submission procedures. We help you interpret and apply local requirements with precision and clarity.
We support your early-stage efforts with classification guidance, submission route analysis, and roadmap development tailored to your device profile and ASEAN goals.
We help integrate Thailand into your broader Southeast Asia strategy, offering advice on CSDT harmonization and country-specific adaptations.
Our feasibility assessments and gap analyses uncover documentation risks and readiness gaps early—reducing downstream registration delays.
Our multilingual team provides clear communication and support across time zones—in Thai, English, Mandarin, German, Spanish, French, Japanese and Korean.
We provide unbiased, preparatory guidance without commercial conflicts—ideal for companies planning entry but not yet ready to register.
Stay informed on regulatory changes, procedural shifts, and strategic developments through our real-time updates and advisory briefings.
Our Core Thailand Medical Device Registration Services
Benefit from focused medical device regulatory services that support informed planning, faster decision-making, and confident preparation for Thailand market entry.
Regulatory Insight & Trends
Localized regulatory updates and tracking
- Monitor Thai FDA announcements, notifications, and guidance
- Interpret risk classification rules and grouping guidance
- Summarize timelines and documentation scope by class
- Share regulatory updates that may impact market access
Actionable insight for global teams
- Provide device-specific regulatory overviews
- Clarify differences between ASEAN and Thai CSDT use
- Advise on future license holder and importer obligations
- Alert teams to procedural and system changes
Strategic Consultation & Planning
Custom market entry strategy
- Confirm product qualification as a medical device or IVD
- Recommend submission routes: general or expedited review
- Advise on bundling and submission structuring
- Map classification and grouping logic across ASEAN
Market readiness and alignment
- Plan license holder and distributor roles for future phases
- Estimate review timelines and identify submission risks
- Integrate Thailand into ASEAN rollout roadmaps
- Advise on importer relationships and logistics setup
Feasibility Review & Gap Analysis
Documentation readiness checks
- Review dossier structure against local CSDT formatting
- Identify missing technical files and inconsistencies
- Evaluate translation scope for Thai language content
- Align IFU, labeling, and claims with Thai FDA requirements
Structured analysis and planning
- Deliver gap analysis with red-flag issues prioritized
- Provide a checklist based on ASEAN CSDT + Thai FDA expectations
- Score document readiness and highlight priority areas
- Offer guidance on internal resource and timeline planning
Thailand Medical Device Regulatory Framework
In the Thai medical device regulatory framework, Class 1 devices (low-risk) undergo a notification process, while Class 2, 3, and 4 devices require registration with increasing levels of scrutiny. All devices must comply with Thai FDA requirements including safety, performance, and labeling, and must receive market authorization before importation or sale.
| Country | Device Classes | LAR Required | Avg. Approval Timeline |
|---|---|---|---|
| Thailand | Class 1–4 | Yes | 6 – 9 months |
Ideal for Companies That:
- Seek early regulatory intelligence and feasibility before formal registration
- Are preparing long-term ASEAN expansion including Thailand
- Want strategic advisory without committing to immediate product launch
- Require expert guidance on high-risk or combination devices
- Prefer building a foundation with a regionally connected regulatory partner
Why Partner with Cisema for Thailand Medical Device Registration?
Proactive Planning for Future Market Entry
Start building your regulatory base in Thailand now. With Cisema’s insight and advisory services, you can plan ahead confidently and avoid costly delays.
ASEAN-Aligned, Country-Specific Support
Thailand is part of our integrated regional service network. While license holding is not yet available, our early-phase services ensure you’re prepared once formal registration begins.
Trusted Partner with Local & Regional Reach
Backed by over 20 years of global regulatory experience, Cisema delivers real-world insight, practical guidance, and multilingual support tailored to Thailand’s evolving regulatory environment.
Key Data for Entering the Thailand Medical Device Market
Thailand is one of the most established and rapidly developing medical device markets in Southeast Asia, supported by a robust healthcare system, aging population, increasing private sector investment, and continuous regulatory enhancement.
Below is a snapshot of essential data to support market entry planning and regulatory strategy.
| Data Category | Details |
|---|---|
| Market Size | Estimated USD 1.9 billion in 2022, projected to grow at 7–9% annually.[1] |
| Population | Approximately 66 million, with increasing healthcare spending.[2] |
| Healthcare Facilities | Over 1,300 hospitals and a robust private sector.[3] |
| Regulatory Authority | Thai Food and Drug Administration (Thai FDA), Ministry of Public Health. |
| Healthcare Expenditure | Approximately 3.8% of GDP.[4] |
| GDP | USD 586 billion (2023).[5] |
[1] Thailand Medical Device Market Outlook Report.
[2] National Statistical Office of Thailand, Population Data 2023.
[3] Ministry of Public Health, Health Infrastructure Statistics.
[4] World Bank, Thailand Healthcare Spending Data.
[5] World Bank, Thailand GDP 2023 Estimate.